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1. INTRODUCTION 
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Nasal Polyps (NP) are common benign noncancerous lesions that arise from the 
mucosa of the nasal or paranasal sinuses, usually at the outflow tract of sinuses, or from the 
cavity of the nasal mucosa (1,2). NP are usually associated with systemic diseases and 
characterized by nasal obstruction, rhinorrhoea, anosmia or loss of smell, post nasal drip, as 
well as headache and facial pain that leads to poor quality of life. NP can be bilateral or 
unilateral and in situations where NP are unilateral other possibilities, although not as 
common, such as benign and malignant pathologies as well as congenital nasal anomalies 
must be ruled out (1).  
NP diagnosis and treatment can possess a challenge for the otolaryngologists due to its 
obscure and sometimes vague etiology and high rate of recurrence. Consensus in regards to 
what constitute a standard therapy is controversial and currently, there is no agreement on 
specific algorithm or approach. Hitherto, management of NP has been primarily based on 
medical treatment and focused on reducing symptoms and improving patients’ quality of life. 
Topical corticosteroids are the usual initial medicament and in severe cases can be combined 
with systemic steroids. Surgery is indicated in cases refractory to medicaments and those with 
complications. NP has been known for millennia and intriguingly it is the first disease in 
human history where both the doctor and patient’s name are recorded (3,4). 
1.1 NASAL ANATOMY 
1.1.1. Skin-Soft Tissue Envelope 
The skeletal framework of the nose is superimposed with the skin soft tissue envelope. 
The nose has a variable skin thickness from superior to inferior part. The skin tend to be 
commonly thickest at the nasion, which is the bony junction of the frontal bone with the two 
nasal bones. The skin soft tissues envelope is usually thinnest at the rhinion, which is the 
osseocartilaginous connection of the caudal part of the nasal bones and cephalic part of the 
upper lateral cartilage. The skin thickens along the dorsum from the rhinion to the nasal tip. 
The sub-cutaneous layer of the skin of the nose is made of a superficial fatty layer, a 
fibromuscular layer and a deep fatty layer as well as periosteum. The fibromuscular layer 
makes the nasal subcutaneous muscular aponeurosis system, which connects with the 
subcutaneous muscular aponeurosis layer of the face. Deep to the skin soft tissue envelope 
lies the nasal musculature (levator labii superioris alaeque nasi, anomalous nasi, alar nasalis 
and depressor septi nasi, transverse nasalis and compressor narium minor, dilator naris 
anterior is a minor dilator muscle). Keratinizing squamous cell epithelium at the nasal 
vestibule forms the internal nasal lining. Pseudostratified ciliated columnar respiratory cells 
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forms the surface inside of the nasal cavity. Nasal cavity also has an abundant number of 
seromucinous gland (5,6). 
1.1.2. Nasal Bony Framework 
The framework of the nose is divided into three parts; the upper third which includes 
the osseous nasal vault made up by the nasal bones, the middle third defined by the upper 
lateral cartilage, and the lower third defined by the lower lateral cartilages. The osseous vault 
makes a pyramidal shaped structure and is composed of the paired nasal bones which attaches 
superiorly to the frontal bone and laterally to the frontal process of the maxilla. The principle 
support of the nose comes from the bone framework along with the bony septum. The caudal 
or free edge of the osseous vault comprises the superior portion of the pyriform aperture, 
(Figure 1), (5,6). 
 
Figure 1. Showing anatomical landmarks where nasal bones and cartilage meet. Taken 
from: Hsu DW, Suh JD. Anatomy and Physiology of Nasal Obstruction, Otolaryngologic Clinic of 
North America 2018. 
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1.1.3. Nasal Septum 
The nasal septum supports the structure of the nose and may be the cause of nasal 
obstruction if significant deformity occurs, which is very common, but usually asymptomatic. 
Birth trauma or micro-fractures early in life may also cause aberrant growth of the septum. 
The anatomy of the nasal septum is made of membranous, cartilaginous, and osseous 
component (from anterior to posterior). The membranous component of the septum consist of 
fibro-fatty tissue and situated between the quadrangular cartilage columella. Quadrangular 
cartilage is the primary constituent of septal cartilage. The posterior nasal septum is made 
from the perpendicular plate of ethmoid, the nasal crest of palatine and maxillary bones, and 
the vomer (5,8,9). 
1.1.4. Turbinates 
Lateral nasal wall has three paired nasal turbinates with their respective meati. The 
ethmoid bone gives rise to the superior and middle turbinates, and the inferior turbinates are 
made of a separate bony structure. The turbinates are thin bones with muco-periosteum 
surface. The inferior turbinate’s submucosal part can hypertrophy in response to exposure to 
chronic allergen or irritants. Also, the middle turbinate can undergo polypoid degeneration. 
The inferior turbinate is responsible in regulation of nasal airflow. It maximizes the intranasal 
surface area and plays important role in humidification and warming of inspired air (10). 
The inferior turbinate is supplied with rich vascular channels that engorges with blood 
and help to explain its effect on nasal obstruction. Congestion of the inferior turbinate 
increases airflow resistance. Changes to the bone or soft tissue of the inferior turbinate also 
narrows the nasal passage. Hypertrophy of the bone or soft tissue can occur in the setting of 
chronic inferior turbinate congestion as seen in chronic rhinitis (Fig. 2). Rarely, 
pneumatisation of inferior turbinates may occur. The middle turbinate is an imperative 
surgical landmark, however, not as important in nasal resistance. Pneumatisation of the 
middle turbinate is shown by concha bullosa which is a common anatomic variant. Conchae 
can be both bilateral and unilateral and are usually asymptomatic and small (Fig. 2). A 
paradoxic middle turbinate, which may cause nasal obstruction is another anatomic variant 
observed in some patients (Fig. 2). Paradox middle turbinate has an infero-medially curved 
free edge as well as a concave surface. When bulbous and air-filled, a paradoxic middle When 
bulbous and air-filled, a paradoxic middle turbinate restricts the middle meatus, which leads 
to ostiomeatal complex blockage and nasal obstruction (10).  
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Figure 2. (A) Coronal computed tomography (CT) showing bilateral inferior turbinate with 
mostly soft tissue hypertrophy (white arrows). (B) Coronal CT showing bilateral concha 
bullosa (white asterisks). (C) Coronal CT showing bilateral paradoxic middle turbinate (white 
arrows). Taken from: Hsu DW, Suh JD. Anatomy and Physiology of Nasal Obstruction, 
Otolaryngologic Clinic of North America 2018. 
1.1.5.  Blood supply and sensory innervation  
The nasal cavity receives its rich blood supply from the terminal branches of the 
external and internal carotid arteries (Fig. 3A). Facial artery, which is the terminal branch of 
external carotid artery, gives off the small superior labial artery to supply the anterior nasal 
septum, and the internal maxillary artery, coursing within the pterygopalatine fossa to give the 
main blood supply to the nasal cavity. The internal maxillary artery gives off the 
sphenopalatine, descending palatine, and infraorbital arteries. Conchal and septal branches 
arise from the sphenopalatine artery. The descending palatine artery, after passing the greater 
palatine canal, becomes the greater palatine artery and enters the nose through the incisive 
foramen and supplies the anterior inferior septum. The anterior and posterior ethmoid 
branches of the ophthalmic artery which are terminal branches of the carotid artery supply the 
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septum and found along the base of the skull. The terminal branches of internal and external 
carotid arteries anastomose to form Kiesselbach area (Fig. 3B) (11). 
 
Figure 3. (A) Nasal cavity blood supply. (B) Internal nasal cavity sensory innervation and 
vasculature. (C) External nasal sensory innervation. Taken from: Hsu DW, Suh JD. Anatomy 
and Physiology of Nasal Obstruction, Otolaryngologic Clinic of North America 2018. 
Terminal branches of the first two divisions of the trigeminal nerve - the ophthalmic 
(V1) and maxillary (V2) nerves innervate the nose. These fibers provide sensation of pain, 
temperature and touch. Superior lateral nasal wall is innervated by the anterior and posterior 
ethmoid nerves (V1). The posterior nasal cavity and lateral nasal wall is supplied by the 
sphenopalatine ganglion (V2). V1 and V2 branches of the internal nasal cavity provide the 
septum. Autonomic nervous system in the nasal cavity is responsible for level of congestion, 
vasculature tone and production of secretions. Cranial nerve I (special sensory branches) at 
the cribriform plate provide olfaction (12). 
1.1.6. Paranasal Sinus  
The paranasal sinuses (ethmoid, frontal, maxillary and sphenoid) are air filled spaces 
located within the bones of the skull and form developmentally through excavation of bone by 
pneumatic diverticula from the nasal cavity (figure 4). They also protect the facial bones and 
serve as a crumple zone to protect the more vital structures in the event of facial trauma. 
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These sinuses are joined to the nasal cavity via small orifices called ostia. Inflammation, or 
swelling in the nasal lining that occurs with a cold can easily block these openings, leading to 
disruption of normal drainage of mucus within the sinuses and can lead to sinusitis (13).  
 
 
Figure 4. Paranasal sinuses. Image on the right shows paranasal sinuses with x-ray. Taken 
from: Reddy UDMA, Dev B. Pictorial essay: Anatomical variations of paranasal sinuses on 
multidetector computed tomography-How does it help FESS surgeons? The Indian Journal of 
Radiology & Imaging Sciences 2012;22(4):317-24. 
1.1.7. Osteomeatal Complex 
 
The osteomeatal unit (OMU) includes the maxillary sinus ostium, ethmoid 
infundibulum, frontal recess and the anterior ethmoid air cells. The OMU (Figure 5) is the key 
factor in the pathogenesis of chronic sinusitis. The ethmoid sinus is the key sinus in the 
drainage of the anterior sinuses. Extreme care is needed during surgery to avoid trauma to the 
OMU due to its close relationship with the orbit and the anterior skull base (13). 
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Figure 5. Coronal CT scan. (A) Shows the osteomeatal complex which consists of the 
following structures: infundibulum (dotted line), hiatus semilunaris (asterisk), maxillary 
ostium (arrow) and the ethmoidal bulla (EB). Middle turbinate (MT), Lamina papyracea (LP). 
(B) Shows agger nasi cell (A) which are inferior and lateral to the nasofrontal recess (solid 
white curved line). The middle turbinate (MT) forms the medial relationship of the recess. 
Taken from: Reddy UDMA, Dev B. Pictorial essay: Anatomical variations of paranasal 
sinuses on multidetector computed tomography-How does it help FESS surgeons? The Indian 
Journal of Radiology & Imaging Sciences 2012;22(4):317-24. 
1.2.  NASAL POLYPS 
NP originate from any part of the nasal mucosa or paranasal sinuses and are an end 
result of different disease processes in the nasal cavities. Patients with chronic sinusitis, 
allergic rhinitis, and cystic fibrosis (CF) can develop multiple polyps. Single polyps could be 
an antralchoanal polyp, a benign polyp, or any benign or malignant tumor such as 
encephaloceles, gliomas, haemangiomas, juvenile nasopharyngeal angiofibromas, papillomas, 
lymphoma, sarcoma, chordoma, or nasopharyngeal carcinoma. All children with benign 
multiple nasal polyps must be evaluated for CF and asthma (1).  
There are two primary types of NP: ethmoidal which arises from the ethmoid sinuses 
and antrochoanal which usually arise in the maxillary sinus. The paranasal sinuses, have 
several functions including; reducing weight of the head, air humidification and aiding in 
voice resonance, and consist of four air filled spaces. Total agenesis of paranasal sinuses are 
rare (Figure 6) , however, isolated frontal sinus agenesis can occur (14).  
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Figure 6. CT scans showing total agenesis of all paranasal sinuses with normal appearing 
nasal septum and conchae. Taken from: Korkmaz H, Korkmaz M. Total aplasia of the 
paranasal sinuses.. Allergy & rhinology 2013;4(2):e105-9. 
NP that extend to the choana, are referred as choanal polyps, constituting roughly 3-
6% of all nasal polyps. There are three main types of nasal choanal polyps (sphenochoanal, 
antrochoanal, and ethmoido-choanal polyps), which exhibit very similar symptoms. The rarest 
of the three is sphenochoanal polyps, while most frequent is antrochonal polyps originating 
from the inflamed sinus mucosa. The sphenochoanal polyps having an unclear etiology, is 
most frequent in adolescents and young adult and can occur concomitantly with other NP 
(Table-1). It is uncommon to see isolated sphenoid sinus pathology. NP symptoms are the 
same (nasal obstruction, nasal discharge, and frequent headaches). Anterior rhinoscopy can 
detect NP, whereas sphenochoanal polyps’ differentiation requires endoscopic examination or 
CT (15,16). 
Functional endoscopic sinus surgery (FESS) can be used to remove NP, but polyps sites of 
origin is imperative, especially those polyps originating from the sphenoid sinus, because of 
the close location of carotid artery and optic nerve to the sphenoid sinus. The risk of damage 
to these essential structures, makes preoperative diagnosis of polyps’ origin essential (17).  
 
Table-1. Ethmoidal vs Antrochoanal polyps characteristics and differences (18). 
 Ethmoidal polyp Antrochoanal polyp 
Age Commonly adults  Commonly children  
Cause Allergic predominance Infectious predominance 
Number Multiple Solitary  
Origin Ethmoidal air cells, uncinated process, 
middle meatus, medial surface and 
edge of middle turbinate 
Maxillary sinus 
Growth Forward anteriorly Backward posteriorly  
Size and 
shape 
Grape like Tri-lobe, Antrum, nasal and choanal part 
Recurrence Common Uncommon 
Colour Pale/Greyish  Red-Pinkish 
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1.3. EPIDEMIOLOGY OF NASAL POLYPS 
         The prevalence of NP widely varies globally and estimated to be around 1-4% in 
western populations, however, in autopsy studies it has been shown to be almost 40%. The 
usual presenting age for NP in adults is between the ages of 20 and 60 years. NP in children 
under 10 years of age may indicate other pathologies such as cystic fibrosis or asthma. In fact, 
NP without other pathologies is rare.  
           Frequency of NP in varies in different diseases, reaching 85% in allergic fungal 
sinusitis. Churg-Strauss syndrome (asthma, fever, eosinophilia vasculitis, and granuloma) is 
associated with 50% of NP cases, while in patients with cystic fibrosis there is 20% frequency 
of NP. It is quite common in patients with asthma (adult, intrinsic, atopic, childhood), with 
chronic rhinosinusitis, allergic and nonallergic rhinitis. Aspirin intolerance has a high 
frequency of NP, 36%, (19). NP has a male predominance, with a ratio of 2-4:1. The 
frequency of NP increases with age, peaking at 50 years of age and older. In children, it is 
extremely low (about 0.1 %), (19,20). 
 
Individuals affected by chronic rhinosinusitis (CRS) (with or without NP) can have 
significantly poor quality of life, “with symptom severity comparable with classically 
debilitating diseases such as congestive heart failure, chronic back pain, and chronic 
obstructive pulmonary disease” (21).  
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1.4. ETIOPATHOGENESIS OF NASAL POLYPOSIS 
1.4.1. Inflammatory Pathway of Nose 
 
Nasal immune system is imperative in identifying and combating inhaled particles 
such as allergens, toxins, and microbes. Innate and adaptive immunity mediate a complex 
immune response. Innate immunity is the first-line nonspecific defense against foreign 
pathogens. This response consists of neutrophils, monocytes, mast cells, dendritic cells, and 
eosinophils. These immune cells act collectively to eliminate infection through the activation 
of a cascade of complement system, natural killer cells, and toll-like receptor (TLR) 
pathways. The adaptive immune response is more specific and acts to combat pathogens 
through immunoglobulin and T-cells. Allergens play a vital role in the pathogenesis of 
aberrant and chronic inflammatory responses in the nose, which can manifest as acute and/or 
chronic rhinosinusitis with nasal polyps. Immunoglobulin E (IgE) hypersensitivity (type I 
hypersensitivity) response is initiated by allergens. Mast cell degranulation and releases of 
histamine and proteases as part of early response causes vasodilation and glandular 
stimulation. Cytokine-mediated influx of eosinophils and activation of TH2 cells constitute a 
late response. Nasal congestion and rhinorrhea occurs as a result (22). 
The exact pathogenesis of nasal polyposis is uncertain. Chronic inflammation, 
autonomic dysfunction and genetic predisposition are linked to polyp development. Most 
literature consider polyps the end result of chronic inflammation and thus conditions that lead 
to chronic inflammation in the nasal cavity can lead to polyp formation. It is mostly believed 
that polyps are strongly associated with non-allergic than allergic diseases. More than 13% of 
non-allergic asthma patients have nasal polyps compare to 5% in allergic asthma patients. 
Some researchers believe NP to be exvagination of nasal or sinus mucosa others class them as 
distinct entities (23,24).  
CRS is a common condition (10.9% of European adult population is estimated to be 
affected), and more than 2.7% of some population have reported NP with CRS.  Four cardinal 
symptoms of CRS are nasal obstruction, post nasal drip, anosmia and facial pain that lasts at 
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least three months. Many patients with CRS present with hyperplastic inflammatory growth 
of the nasal polyps in their nasal airways (25). CRS with NP (CRSwNP) is more prevalent in 
male than female (ratio 1.3 to 12.2) and incidence peaks between the ages of 45-65 (26,27).  
Aspirin-exacerbated respiratory disease (AERD) also known as Samter’s triad consists 
three main features such as asthma, sinus disease with recurrent NP and sensitivity to aspirin 
and other cyclooxygenase (COX) inhibitors (NSAIDS). Patients with AERD often present 
with severe forms of asthma and NP. It has been estimated that between 0.6-2.5% of general 
population suffers from AERD (28,29). 
Due to some unknown mechanisms type 2 inflammation is often seen with CRSwNP 
in Western populations with elevated levels of certain type 2 cytokines, such as IL-5 and IL-
13, and with eosinophilia. However, in Far East countries CRSwNP is characterized by type 1 
and/or type 3 inflammation, with a more neutrophilic inflammation than seen in NP in 
Caucasian populations (30). 
Patients with CRSwNP are observed to have their sinuses and upper airways 
chronically colonized with fungi and bacteria and believed by many researchers that these 
microbes may play an essential role in CRSwNP pathogenesis. However it is not certain 
whether this is an initial cause of CRSwNP or a downstream effect of the inflammatory 
disease. In fact, Sasama et al. suggested fungi to be the main cause of all CRS pathologies and 
hypothesized that fungi to be responsible for the cardinal features of CRS such as epithelial 
damage and activation of immune system. However, the hypothesis was rejected to be the 
central cause of CRS in patients. Staphylococcus aureus (SA) bacteria has also been the focus 
in CRSwNP. Some researchers believe that SA and its super-antigens may play a vital role in 
the pathogenesis of CRSwNP, as it has been established in atopic dermatitis. Due to super-
antigens potential to activate large numbers of T cells, and their capacity to bind a large 
number of T-cell receptors, independent of MHC-II recognition mechanisms required by 
classic antigens. Using flow cytometry, increased levels of super-antigen-binding T cells in 
NP have been identified and it has been observed by many researchers that some patients with 
CRSwNP have super-antigen-specific IgE in their NP. Therefore, it is believed that SA plays 
at least some crucial role in the chronic inflammatory response of patients with CRSwNP 
(25,31,32).  
The first line of defense against pathogens comes from the epithelial layer of the 
airways which is essential for keeping homeostasis of the underlying mucosa. Most basic 
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function of epithelial layer is to form tight junctions between cells to create a physical barrier 
between the airway lumen and the underlying submucosal tissue. It is widely accepted that 
defects in the airway epithelial barrier function are responsible for chronic airway diseases 
such as asthma (24,33).  
Sinonasal epithelial barrier damage in CRSwNP patients has also been observed such 
as diminished expression of tight junction proteins with increased epithelial permeability. 
Type 2 cytokines, such as IL-4 and IL-13, and pro-inflammatory cytokines, such as oncostatin 
M (OSM), seen to play a role in decreasing function of tight junction and increasing epithelial 
permeability. These defects in barrier function may play a critical role in the pathogenesis of 
CRSwNP by letting in foreign antigens into the submucosa and triggering inflammatory 
response, as has been shown in patients with asthma. Production of mucus and motility of 
cilia, which is essential for prevention of interaction of luminal antigens and pathogenic 
organisms with underlying tissue, is also defective in CRSwNP. Inadequate clearance of 
foreign antigens contribute to development of inflammation (23,33,34).  
Some of the molecules that are altered in CRSwNP, and may cause dysfunction in the 
formation of nasal lining fluid, include Pendrin, periostin and PLUNC family member 
molecules are important in formation of nasal lining fluids and are altered in CRSwNP. 
Carriers of one mutated CFTR gene that do not have CF, are high risk of developing 
CRSwNP, further supporting the idea that the components of the nasal lining fluid is 
disturbed in CRS. The epithelial cells in the airways also have inducible innate immune 
function that are responsible for recognizing pathogens, and activating immune cells. Pattern 
recognition receptors (PRRs), such as toll-like receptors (TLRs), are responsible for 
pathogens recognition and initiate downstream immune responses, are expressed by the 
airways. Evidence in regards to TLR defect in the pathogenesis of NP or CRS are conflicting, 
some suggests TLR are increased and thus lead to unnecessary inflammatory response while 
others TLR level is decreased and the disease fail to control the pathogenic organism (35,36).  
In NP formation and CRS, level of various cytokines and chemokines have been 
reported to be altered. Chemokines are important protein molecules for the attraction of 
neutrophils, eosinophils, macrophages, dendritic cells, T and B cells. Eotaxin 1 (CCL11), 
eotaxins 2 (CCL24) and 3 (CCL26), are the main CCR3 activating chemokines that is 
responsible for recruitment of eosinophils, which is highly elevated in NP. Moreover, NP 
derived fibroblasts or airway epithelial cells express CCL11 which is increased by the 
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combination of IL-4, or IL-13, and TNF in vitro which indicates that there might be a positive 
feedback loop for eosinophil accumulation that is further increased in a pro-inflammatory 
type-2 inflammatory domain (37-39).  
Figure 7. Role of type-2 inflammation in the mediation of CRS and NP formation. Type 2 
cytokines are derived from Th2 which are activated by antigen-presenting cells (APC), 
including Dendritic Cells, B cells and others. IL-4, IL-5 and IL-13 drive the recruitment and 
activation of mast cells, eosinophils, basophils, goblet cells, M2 macrophages, and B cells. 
Taken from: Hulse KE, Stevens WW, Tan BK, Schleimer RP. Pathogenesis of nasal 
polyposis. Clinical and experimental allergy.: Journal of the British Society for Allergy and Clinical 
Immunology 2015;45(2):328-46.  
1.5. DIAGNOSIS  
The evaluation of NP begins with a detailed personal history. Nasal obstruction is the 
most common symptom, which depends on the size of the NP. Rhinorrhea, postnasal 
drainage, anosmia or hyposmia, headache, facial pain, changes in quality of the voice and 
sense of taste are other frequent symptoms. Benign multiple polyps almost never cause 
epistaxis and if present may suggest a more serious nasal cavity lesion. Polyps may block the 
outflow tract of the sinuses and cause chronic or recurrent acute sinusitis.  
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         NP can be single or multiple, bilateral, mobile, smooth and semi-translucent polypoid 
masses in the nasal cavity, which can be seen in physical examination and anterior 
rhinoscopy. Middle meatus is the most frequent site for NP but can also occur in the mucosa 
of the ostia, anterior and posterior ethmoidal clefts, as well as the frontal and spheno-
ethmoidal recesses. Nasal endoscopic examination provides excellent visualization of the 
polyps in the middle meatus. Endoscopic visualization of the polyps and adjacent regions of 
the nasal and sinus cavities is absolutely necessary for an accurate diagnosis and staging of 
the disease. Lildhodt’s staging is usually used (Table 3), (1,9). 
 
 Table 3. Lildhodt’s grading of nasal polyps (1). 
Endoscopic Appearance Score 
No polyps 0 
Polyps restricted to middle meatus 1 
Polyps below middle turbinate  2 
Massive polyposis  3 
. 
Plain X-rays have a limited value in diagnosis of NP. Computerized tomography (CT) 
scanning is the method of choice, although not the primary choice. It must only be utilized in 
unilateral cases and for patients which surgical treatment is considered. A CT scan in 
imperative to define the relationship of the optic nerves and carotid arteries prior to the 
surgery. MRI is only preferred to differentiate meningocele or encephalocele, due to its poor 
bone resolution, and to distinguish tumors from inflammatory disease (1). 
For quantification of the restriction in the nasal airway; anterior rhinomanometry, and 
nasal inspiratory peak flow can be used. Other useful and important tests are; pulmonary 
function tests, allergy tests, biopsies, sweat chloride test (genetic testing for the detection of 
cystic fibrosis), aspirin intolerance test, fungal cultures and stain, and tests of smell 
(University of Pennsylvania Smell Identification Test) (1,2).  
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1.5.1. Differential diagnosis 
 
Patients with unilateral NP must undergo further tests to rule out other clinical 
pathologies (Table 4). Similarities of benign and malignant disorders presentation should be 
kept in mind and must not delay the diagnosis of malignancy. NP symptoms unresponsive to 
medical treatment, orbital symptoms, epistaxis, severe and unilateral frontal headache, focal 
neurological signs must alert the physicians of other more distinct diseases (2). 
 
 Table 4. Differential diagnosis of nasal polyposis  
 
 
 
 
 
 
 
 
 
 
      
 
 
 
 
   
Children  
Turbinate hypertrophy 
Congenital  
Nasolacrimal duct cysts 
Nasal gliomas 
Encephaloceles 
Tumors 
Juvenile nasopharyngeal angiofibroma (JNA)  
Rhabdomyosarcoma 
Hemangioma 
Chordoma 
Adults 
Inverted Papilloma 
            Tumors 
Squamous cell carcinoma 
Nasal lymphomas 
Nasal melanoma 
Esthesioneuroblastoma 
Hemangiopericytoma 
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                                                                                                                1.6. TREATMENT            
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         Management of NPs involves combination of observation, medical, and surgical, or both 
medical and surgical therapy, depending on individual case assessment.  The treatments aim 
to eliminate and reduce the size of the NP, thus, improving sinus drainage, relief of nasal 
obstruction and restoration of olfaction and taste (20). Topical or systemic steroid regimens, 
nasal saline lavage and allergen immunotherapy are used as part of medical therapy. Current 
guidelines (Figure 8) recommend benign NP should be initially treated conservatively, as 
surgery may not be necessary in many patients. Surgery should only be attempted if medical 
therapy fails to control symptoms and also to remove the fungal debris if Allergic Fungal 
sinusitis exists. Surgery can also help to prevent the complications in cases with erosion of the 
lamina papyracea and the skull base. Surgery is not utterly curative and usually long term 
medical therapy is required, because NP cannot be excised completely. Recurrence rate is 
high, in particular, in asthmatic patients (40,41).  
Figure 8. Management of chronic rhinitis with nasal polyps (1). Taken from: Cingi C, 
Demirbas D, Ural A. Nasal polyposis: an overview of differential diagnosis and treatment. 
Recent patents on inflammation & allergy drug discovery. 2011;5(3):241-52. 
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1.6.1. Medical treatment 
 
Medical treatment approach should be based on individual bases. Treatment options 
consists of topical and systemic steroids, nasal lavage, antibiotic therapy, antifungal therapy, 
antileukotrienes, antihistamines, as well as aspirin desensitization. Currently, intranasal 
glucocorticoids (GC) is the best treatment of NP. Steroids are able to decrease polyp size, 
improve nasal airway patency, improve rhinorrhoea, and nasal blockage. Steroids constitute 
an imperative part of post-op therapy and delay the recurrence of polyps after surgery. GC 
have excellent anti-inflammatory property and exert their effect by reducing secretion of 
chemotactic cytokines, inhibiting the activity of T-cells and eosinophils (42,43).  
Non-steroidal treatment includes: antibiotic, antifungal, antihistaminic, 
antileukotrienes and saline nasal irrigation. Antibiotic therapy is used if chronic or recurrent 
acute sinusitis, due to sinus obstruction, occurs and should be directed against 
Staphylococcus, Streptococcus, species and anaerobes as well as Pseudomonas aeruginosa 
(common in CF).  Macrolides use exert anti-inflammatory rather than anti-microbial effect, 
inhibit expression of adhesion molecules, which are involved in inflammatory cells 
recruitment, and diminish IL-8 in nasal lavage and decrease the size of NP. Fungi and their 
spores are part of inspired air and is commonly present in the nose. Some studies suggested 
fungi to be the cause of chronic sinusitis and NP (allergic fungal sinusitis). Lund-Mackay 
staging is used to measure diseases severity. Aggressive surgical procedure is required in 
cases of perceived fungal invasion (44,45).  
Antihistamines are not the first choice in NP but can be used for seasonal allergy or 
when there is exposure to and allergen (46). Antileukotrienes have shown significant efficacy, 
particularly with the use of zafirlukast and zileuoton, in reducing symptoms NP symptoms 
(47). Aspirin desensitization therapy is shown to reduce symptoms in NP patients with AERD 
and also improvement in olfaction, reduction in sinus infection and asthma exacerbation and 
decreased sinus and polyp operations were reported (48).  Baudoin et al. reported reduction in 
massive polyposis after five days of increasing dose of topical capsaicin but its unpleasant 
burning sensation is limiting its use (49). In NP patients with aspirin intolerance, topical 
administration of lysine acetylaceticylate (LAS) is reported to be effective, in particular those 
with the Samter’s triad. However, local treatment with LAS seems in effective in patients 
without aspirin intolerance (50).  
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1.6.2. Surgical Treatment  
 
Primarily, conservative medical therapy with steroids is the preferred choice, but due 
to the side effects of steroids and high recurrence rate, surgery is often necessary.  For 
complicated cases, persistent infections, and unilateral NP surgery is the mainstay treatment. 
Surgery significantly reduces the size of NP, improves sinus drainage and can restore 
olfaction and taste. Asthmatic patients, in particular, tend to benefit more from surgical 
excision of polyps. Surgical technics have been significantly improved over the years and 
FESS has become the main method for NP excision (51).  
1.6.2.1.Intranasal polypectomy 
 
Nasal polypectomy is indicated for uncontrolled symptoms and those that failed 
optimum medical therapy. After development of endoscope, this procedure has become safe 
and mortality is very rare nowadays. It is performed using forceps and by cutting or avulsion 
of the polyps (52). 
1.6.2.2.Intranasal Ethmoidectomy 
 
Intranasal ethmoidectomy historically had high mortality due to poor visualisation of 
the anteriori cranial fossa during surgery. Current ethmoidectomies are carried out under 
endoscopic approach and middle turbinate is totally excised to provide exposure to the 
ehtmoids. Most surgeon no longer perform this surgery due to the risk of damage to the orbit 
and or base of the skull (53). 
1.6.2.3. External Ethmoidectomy 
 
External ethmoidectomy is performed under general anaesthesia and an incision is 
made between the medial canthus and the midline of the nose. The surgeon then lifts the 
periosteum posteriorly into the orbit until the anterior ethmoidal artery is identified. In the 
posterior ethmoids the skull base is identified. Limits of the dissection is guided by the basal 
lamella. Any diseased mucosa, polyps, or tumours should be removed, once the ethmoids are 
opened. Then the orbit is displaced laterally and all ethmoid cells are removed (53). 
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1.6.2.4. Caldwell-Luc 
 
In Caldwell-Luc method an incision is made in the gingivobuccal sulcus, above the 
canine fossa, and extended through the periosteum over the maxilla. Then the periosteum is 
lifted superiorly and the infraorbital nerve is identified. Using osteotome, an outline window 
is made in the maxillary antrum. The window can be enlarged using a drill if required. Care 
must be taken to avoid injury to the secondary dentition and the infraorbital nerve. The 
Caldwell-Luc is used in polypoid disease, fungal sinusitis, antrochoanal polyps, and benign 
tumors (53). 
1.6.2.5. Functional Endoscopic Sinus Surgery (FESS) 
 
FESS is the cornerstone of modern surgical treatment for NP. It is a minimally 
invasive technique, which uses an endoscope and its advantages over surgery without an 
endoscope includes: a better view of the surgical field, precise and thorough clearance of 
inflamed tissue, far less complications and, lower recurrence rates (54).  
 Two approaches are common in FESS. Messeklinger technique (front to back) begins 
with visualization with a zero-degree (0º) endoscope. The procedure includes: uncinectomy, 
removal of the ethmoid bulla, exposure of the frontal sinus ostium, and identification of the 
roof of the ethmoid. After identifying the skull base, the dissection continues posteriorly and 
anterior ethmoid cells and the posterior ethmoid cells are removed, and finally sphenoid sinus 
is opened. With a 30-degree telescope, the ostium of the maxillary sinus is identified. In 
Wigand technique (back to front), the sphenoid sinus is identified first. The skull base and 
lateral wall is used as landmarks, then the ethmoid sinuses are cleaned from posterior-
anteriorly. Giving an early exposure to the skull base, which is a major advantage of this 
procedure (2,55).  
The microdebrider enables accurate removal of NP whilst preserving normal 
anatomical structures and also functions as suction and keeps the surgical field clear. 
Microdebrider reduces the blood loss and improve the visualization with a rapid removal of 
polyps. Serious complications of ESS are rare but the patient must be counseled 
preoperatively about the potential risks such as loss of vision, damage to the internal carotid 
artery, and cerebrospinal fluid leakage after inadvertent trauma to the skull base (1,2). 
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2. OBJECTIVES OF RESEARCH 
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The aims of this study are to establish the demographic and characteristics of patients 
operated by the FESS method due to nasal polyposis. The objectives of the study are to 
determine what age group of patients mostly underwent NP surgery, which gender undergoes 
FESS method more and in which season of the year the most surgical procedures take place 
and to compare them with other relevant studies. 
 
Hypothesis: the FESS method is an effective method of treating nasal polyposis with 
excellent healing results and a low complication rate. The method meets criteria for minimally 
invasive ENT surgery. 
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3. MATERIALS AND METHODS 
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Inclusion criteria: 
1. Patients of both genders, any age group, with nasal polyposis treated by the FESS           
method 
2. Patients operated in University Hospital of Split by a specialist in otolaryngologist surgery  
3. Patients treated by the FESS method in the period from January 2013 to January 2018. 
 
Exclusion criteria: 
1. Patients with nasal polyposis treated surgically with another method than ESS method 
2. Patients operated in another institution 
3. Patients with incomplete data  
 
 
3.1. Organization of the study 
         Historical retrospective study. Research is a quantitative research according to the 
organization, while intervention and processing of the data are descriptive, ie descriptive type. 
All patients were treated with FESS method for nasal polyposis at the Department of ENT, 
head and neck surgery of the University Hospital of Split in the period from January 2013 to 
January 2018. 
 
 
 
3.2. Place of the study 
The research was conducted at the Department of ENT, head and neck surgery of the 
University Hospital of Split. 
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 3.3. Methods of data collection and processing  
Data was collected by research of the written protocol of the Department of ENT, head 
and neck surgery, University Hospital of Split, and the archive of the history of the disease. 
Collected 371 patient data and were analyzed using Microsoft Word Processing Software, 
version 14 (Microsoft Word Software, Redmond, Washington, USA), Microsoft Excel, 
version 14 (Microsoft Excel Softwere, Redmond, Washington, USA) and the statistical 
software MedCalc for Windows, version 14.8.1 (MedCalc Software, Mariakerke, Belgium) 
for table presentation. 
 
 
 3.4. Description of research  
All 371 patients underwent surgical procedure in the period from 1st January2013 to 1st 
January 2018 due to nasal polyposis and the FESS method was used.  
 Surgery implied removal of polyps through nostrils with the help of nasal endoscope. 
The FESS method enlarges the drainage pathways of the sinuses and fixes any other issues 
interfering with drainage, thus preventing any further build-up of mucus. The following 
parameters were analyzed for each subject: age, gender, season and the year of the surgical 
procedure.  
Statistical analysis was done by the statistical software MedCalc for Windows, version 
14.8.1. (MedCalc Software, Mariakerke, Belgium), using chi-squared-test. Statistical 
significance was set at p<0.05. 
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4. RESULTS 
28 
 
In the selected study period (2013–2018), the study included 371 patients (121 female, 
250 male) operated by the FESS method due to nasal polyps. The median age at the time of 
the operation was 54 years (12-77 years). Demographic, categorical and ordinal data are 
presented in Table 4.  
 
Table 4. Demographic, categorical and ordinal data 
Demographic data of the patients                   n= 371  
GENDER (n, %) 
           Female                                                   121 (32.6)  
           Male                                                       250 (67.4) 
AGE (Years) 
           Median                                                        54  
           Range                                                        12-77  
 
 
Categorical and ordinal data of the patients              n= 371 
 
SEASON (n, %)  
          Winter:   Female                                     25(20.7)  
                         Male                                         77 (30.8) 
          Spring:    Female                                     42 (34.7)  
                           Male                                       76 (30.4)  
          Summer:  Female                                    20 (16.5)  
                           Male                                       50 (20.0)  
 
          Fall:          Female                                   34 (28.1)  
                           Male                                       47 (18.8) 
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   Table 5. Number of subjects from each year 
Year No. of Subjects 
2013 101 (27.2) 
2014  75 (20.2) 
2015  56 (15.1) 
2016  76 (20.5) 
2017  63 (17.0) 
 
 
 
Among the 371 patients with nasal polyps who underwent the FESS operative 
procedure, 121 were female (32.6%) and 250 were male (67.4%). The average age of the 
patients with nasal polyps included in the study was 54 years old, with a range of 12 to 77 
years old. In respect to age, nasal polyps were most common in the fifth decade of life. Most 
of the ESS operative procedures occurred in the spring, followed by winter and summer, and 
it was rarest in the fall. Most of the patients were operated in 2013. 
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Figure 8 shows the distribution of patients by gender. Out of a total of 371 patients 
treated with the FESS method for nasal polyposis, there were 121 female, which makes up 
32.6% and 250 male, which is 67.4% (approximate 2:1 male to female). This relationship is 
valid overall, with variations of the year-to-year ratio.  
 
 
Figure 8. Gender distribution of the patient sample (n= 371). 
 
 
Figure 9 shows the age distribution of the patient sample. The 371 patients treated with 
FESS method due to nasal polyposis were between 12 and 77 years of age. Median age of the 
sample was 54 (95 CI 52-56) years. Female median age was 52 (47-55), and the male median 
age was 54 (52-57). 
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Figure 9. Age distribution of the patient sample (n= 371).    
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Figure 10 shows distribution of patients by the season of the year. Out of total 371 patients, 
77 male were operated in winter (30.8%), making it the season with the most male patients 
being operated. For females, spring was the season when 42 of them were operated, making it 
the highest season distribution of the female patient sample (34.7%). Overall, spring season 
had the highest incidence of FESS operative procedure with total of 118 (31.8%) patients, 
followed by winter102 (27.5%). The number of ESS procedure decreased in fall, with 81 
(21.8%) patients, and the lowest number of patients were operated in the summer season, with 
70 patients being operatd (18.9%). 
 
 
 
 Figure 10. FESS operative procedure distribution by the season of the year. 
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Figure 11 shows the incidence of nasal polyposis FESS surgical treatment in the study sample 
between 2013-2018 year. Out of 371 patients who underwent FESS surgical method, 101 
were operated in 2013, which makes up 27.2% of total FESS procedures and the year with 
highest occurrence of FESS procedure. There was a slight decrease in the number of FESS 
preformed in the following two years, 2014 and 2015, followed by an increse in 2016, with 76 
patients (20.5%) who underwent operation. In 2017 there was again a slight decrease in the 
number of operated patients, with 17 FESS procedures (17.0%). From this figure we can 
conclude that there was a decrease in incidence of nasal polyposis ESS surgical method 
observed in this study period. 
 
  
 
Figure 11. The incidence of FESS surgical method in the study period between 2013-2018. 
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5. DISCUSSION 
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Nasal polyposis is one of the common diseases in the Ear, Nose and Throat (ENT) 
department. The etiology and formation of NP, however, are uncertain, despite decades of 
research. The current knowledge is that chronic inflammation and nasal allergy are the two 
most important factors associated with this lesion. The level and type of inflammatory 
markers have been observed to vary greatly across the globe. This potential difference in 
pathogenesis is probably due to the variability in patients’ gene and the environment or it 
could be that NP are an ultimate end result of different diseases (1).  
The epidemiology of NP also varies between the east and west. The potential causes of 
this variability in estimated prevalence could also be due to the use of different diagnostic 
criteria and inconsistent diagnostic definitions. NP can be clinically silent and 
epidemiological studies are usually based on a mix of subjective and objective data. Anterior 
rhinoscopy or nasal endoscopy evaluation is used in objective evidence collection for NP. 
Whereas, subjective measures generally rely on patient-report surveys and thus, can lead to 
under or overestimation of the actual prevalence. However, the literature does suggest that 
CRSwNP increases with age and NP is uncommon under the age of 20 years. NP are more 
common in men than in women but aspirin sensitive patients, however, are more likely to be 
women (56). 
When discussing NP treatment, it is rather important to classify and stage nasal 
polyposis in order to decide the magnitude of the disease and to dedcide the optimal 
management modality. NP may be different types and may come from different origins and 
therefore, require different treatment. Moreover, information obtained from research may 
apply to one type of polyp but not to another. Due to above reasons, it is necessary to use 
classification system of NP. Physical examination with special visualization of the nose 
should be included in the procedure. Nasal scraping should be used to identify predominant 
cells such as eosinophils, lymphocytes, and neutrophils. More than 80% of NP are reported to 
be eosinophilic type. Inclusion of other tests, such as microbiology, CT scan, MRI and 
immunologic evaluation, can further enhance the benefit of this classification in appropriate 
treatment of patients (19).  
Since the advent of minimally invasive FESS, NP treatment has been revolutionized 
and patients report huge improvement in their quality of life. However, very serious 
complications can arise. Dalziel et al. carried out a systematic review of safety and 
effectiveness of ESS in which they reported a wide range of complication rates (0.3-22.4% 
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with median of 7.0%). Nevertheless, the major complications were low (0-01.5%), which 
included: CSF leak, injury to the internal carotid artery, and meningitis and orbital 
penetration. Most frequent complications entailed: hemorrhage, rhinorrhea and orbital fat 
exposure (55).  
Data obtained from the University Hospital of Split (KBC) shows very similar pattern 
to those of other Caucasian countries. The data shows NP to be more common in male, than 
female in all age groups, and the incidence peaks around the age of 50-65 years (figure 9). 
There are also seasonal variation in regards to the number of surgeries performed. Number of 
surgeries performed are lowest in the summer and highest during spring (Figure 10). 
The study had some limitations, like data collection process from the written protocol, 
which was sometimes impossible to read. Split is a small town, so the study period of 5 years 
(2013-2018) included  371 patients, which is a quite low sample size for that time period.. 
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6. CONCLUSION 
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The data obtained from the Department of ENT, head and neck surgery, University 
Hospital of Split, shows very similar nasal polyp demographic pattern to the data obtained 
from other countries. In the selected study period (2013–2018), the study included 371 
patients (121 female, 250 male) operated by the FESS method due to nasal polyps. The 
median age at the time of the operation was 54 years (12-77 years). Among the 371 patients 
with nasal polyps who underwent the FESS operative procedure, 121 were female (32.6%) 
and 250 were male (67.4%). The average age of the patients with nasal polyps included in the 
study was 54 years,   with a range of 12 to 77 years old. In respect to age, nasal polyps were 
most common in the fifth decade of life. Most of the FESS operative procedures occurred in 
the spring, followed by winter and summer, and it was rarest in the fall. Most of the patients 
were operated in 2013.   
There are great variability in the prevalence rate and surgery outcome of Nasal Polyps. 
Therefore, researchers should be required to precisely describe the characteristics of polyps in 
their data. It is well known that different types of polyps differ in their treatment as well as 
recurrence rate and prognosis. In the field of NP; standardization of medical knowledge, 
appropriate differential diagnosis, standardized treatment, and a classification system is 
needed to avoid the current confusion and allow surgeons and other physicians to practice 
evidence based medicine (EBM). There are many ambiguities in NP incidence and 
pathogenesis. Further research should focus on the individual theories as a cause of NP 
formation. Comparison of Western- Eastern NP incidence data would also be a substantial 
contribution, as there is paucity of data in this field.  
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Incidence of nasal polyps at the Department of ENT, head and neck surgery, University 
Hospital of Split, between 2013 – 2018; a retrospective study.  
Objectives: To determine what age group of patients mostly underwent NP surgery, which 
gender undergoes FESS method more and in which season of the year the most surgical 
procedures take place and to compare them with other relevant studies. 
 
Material and Methods: Data was collected by research of the written protocol of the 
Department of ENT, head and neck surgery, University Hospital of Split, and the archive of 
the history of the disease. Collected 371 patient data and were analyzed using Microsoft Word 
Processing Software, version 14 (Microsoft Word Software, Redmond, Washington, USA) 
and Microsoft Excel, version 14 (Microsoft Excel Software, Redmond, Washington, USA) 
and  statistical software MedCalc for Windows, version 14.8.1 (MedCalc Software, 
Mariakerke, Belgium). 
Results: In the selected study period (2013–2018), the study included 371 patients (121 
female, 250 male) operated by the FESS method due to nasal polyps. The median age at the 
time of the operation was 54 years (12-77 years). Among the 371 patients with nasal polyps 
who underwent the FESS operative procedure, 121 were female (32.6%) and 250 were male 
(67.4%). The average age of the patients with nasal polyps included in the study was 54 years,   
with a range of 12 to 77 years old. In respect to age, nasal polyps were most common in the 
fifth decade of life. Most of the FESS operative procedures occurred in the spring, followed 
by winter and summer, and it was rarest in the fall. Most of the patients were operated in 
2013.  
Conclusion: There are great variability in the prevalence rate and surgery outcome of nasal 
polyps. Overall, obtained data indicates similar demographic pattern to those around the 
world.  
 
 
 
 
 
45 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9. CROATIAN SUMMARY  
46 
 
Naslov: Incidencija operacije nosnih polipoza na Klinici za bolesti uha, nosa i grla s 
kirurgijom glave i vrata, Kliničkog bolničkog centra Split, u razdoblju od 2013-2018, 
retrospektivna studija. 
 
Ciljevi: Odrediti koja dobna skupina pacijenata se najčešće podvrgnula operativnom zahvatu 
nosnih polipoza, koji spol je učestaliji, u koje godišnje doba je bilo najviše FESS zahvata te ih 
usporediti sa relevantnim studijama. 
 
Materijali i metode: Svi podaci su prikupljeni iz pisane dokumentacije i arhive povijesti 
bolesti sa odjela Klinike za bolesti uha, nosa i grla s kirurgijom glave i vrata u Kliničkom 
bolničkom centru Split. Prikupljeni podaci o ukupno 371 pacijenta je analizirano koristeći 
Microsoft Word Processing Software, verzija 14 (Microsoft Word Software, Redmond, 
Washington, USA), Microsoft Excel, verzija 14 (Microsoft Excel Software, Redmond, 
Washington, USA) te statistički software MedCalc for Windows, version 14.8.1 (MedCalc 
Software, Mariakerke, Belgium).  
 
Rezultati: U vremenskom razdoblju od siječnja 2013 do siječnja 2018 retrospektivno su 
pregledane povijesti bolesti 371 pacijenta (121 žena, 250 muškaraca) liječenog FESS 
metodom odstranjivanja nosnih polipoza. Prosječna dob pacijenata za vrijeme operacije je 
bila 54 godine (12-77 godina). Od 371 pacijenta koji se podvrgnuo FESS operativnom 
zahvatu, 121 su bile žene (32.6%), a 250 muškarci (67.4%).  Najviše se pacijenata podvrgnulo 
FESS operaciji u proljeće, zatim zimi te ljeti, dok je u jesen bilo najmanje FESS operativnih 
zahvata. Većina pacijenata je operirana 2013 godine. 
 
 
Zaključci: Postoje velike razlike u prevalenciji i operacijskom ishodu nazalnih polipoza. 
Dobiveni podaci ukazuju na sličan demografski uzorak  diljem svijeta. 
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